Abstract
Abstract The degradation of six representative emerging pharmaceuticals (PhACs) (carbamazepine (CBZ), crotamiton (CRMT), N,N-diethyl-meta-toluamide (DEET), gemfibrozil (GEM), ibuprofen (IBP) and trimethoprim (TMP)) mixture in municipal secondary effluents by UVC-activated HSO5− and S2O82− were investigated and compared to UV/H2O2 process. The results showed that the PhACs degradation efficiencies by UV/HSO5− were typically smaller than those obtained by UV/H2O2. In contrast, UV/S2O82− offered larger degradation efficiencies of CBZ, GEM, IBP and TMP in comparison to UV/H2O2, which however was less effective in degrading CRMT and DEET. The electron spin resonance (ESR) and radical scavenging tests indicated that hydroxyl radical (HO•) was the major reactive species responsible for the degradation of PhACs by UV/HSO5−, while both sulfate radical (SO4•−) and HO• contributed to PhACs degradation by UV/S2O82−. The rate constants of PhACs reacting with HO•/SO4•− were determined on the basis of their degradation kinetics. All PhACs have large rate constants with HO• over the range of (7.66–9.86) × 109 M−1 s−1. Among of them, CBZ, GEM, IBP and TMP have large rate constants with SO4•− at (1.48–4.59) × 109 M−1 s−1. However, CRMT and DEET have smaller rate constants with SO4•− at 2.84 × 108 and 2.95 × 108 M−1 s−1, respectively, thereby resulting in limited degradation efficiencies by UV/S2O82−. The degradation intermediates of PhACs were investigated and tracked by LC-QTOF-MS. Evolution of effluent organic matters (EfOM) was investigated by means of excitation-emission fluorescence matrices (EEFM), indicating successful destruction of EfOM by HO•/SO4•−. The reaction stoichiometric efficiencies (RSE) of Δdissolved organic carbon (DOC)/Δoxidants were compared, suggesting high oxidant utilization efficiencies for UV/HSO5− and UV/S2O82− at 66.8% and 52.0%, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.